The Respiratory Drug Delivery (RDD) Europe 2013 scientific conference, to be held in Berlin on May 21-24, 2013, will see pulmonary and nasal drug delivery experts from all over the world.
The joint organisers of the event, RDD Online and Aptar Pharma, have announced the opening of registration at:www.rddonline.com/rddeurope2013. More than 450 delegates are expected to attend the meeting to be held at the Intercontinental Hotel Berlin. The scientific symposium will welcome an audience of high level academic, industrial and regulatory experts involved in the research, development, investigation, and marketing of existing and new therapies for delivery through the nose or lungs.
The meeting will begin with a plenary lecture titled ‘Biomarkers and Targeted Treatments for Small Airways Diseases – The Past, Present and Future’ presented by Dr DS Postma, Professor at the Department of Pulmonary Medicine and Tuberculosis, University Medical Centre Groningen, Groningen, The Netherlands.
The symposium will also focus on: Drug Development — New Drugs, Targets and Formulations; Weighing the Evidence in Support of Bioequivalence; Orphan drugs – Opportunities, Regulatory and Clinical Challenges; Harmonising the Clinical Requirements for LABA/ICS Combinations in the US and Europe; Designing Devices for the Marketplace; Optimising Formulation and Device Partnerships.
As part of the event, RDD Europe conferences highlight innovative research contributions through podium and scientific poster sessions. These are enhanced by 12 technical interactive workshops from vendors and service providers in the industry. In all sessions, the latest technological advances related to nasal and pulmonary drug development will be presented.
RDD Europe 2013 will feature an expanded high-profile exhibition showcasing the latest technologies and equipment in this exciting field. RDD Europe 2013 offers numerous opportunities for networking, including a cocktail reception on the evening of May 21.
RDD conferences take place in both Europe and the US in alternate years and are widely regarded as the premier venue for presenting the latest pulmonary and nasal drug delivery advances. Last year, RDD 2012 was held in Phoenix, Arizona.
EP News Bureau – Mumbai
